Emerson Electric Co (EMR) reports robust Q4 performance with a 6% order growth and plans to return $2.2 billion to shareholders in 2026.

New York, November 9, 2009 - That's the question users of glucose monitors and other point-of-care (POC) tests may ask, according to a leading healthcare market research publisher. As wireless ...

Emerson Electric’s (EMR) shares fell 7.2% in premarket trading Wednesday after the industrial automation company reported ...

AUSTIN, Texas, May 6, 2024 /PRNewswire/ -- Emerson's (NYSE: EMR) Test and Measurement business, formerly NI, today announced its premier NI Connect event will showcase the latest in intelligent NI ...

PALO ALTO, Calif., May 4, 2011 /PRNewswire/ -- ARIA® for medical oncology (Version 10 MR2), an electronic medical record (EMR) and clinical practice management system, has been certified for use by ...

Emerson Electric Company ( ($EMR) ) has provided an update. On November 5, 2025, Emerson Electric Co. announced its Board of Directors authorized ...

Doctors are reporting challenges when it comes to accessing electronic medical record (EMR) data for patients with coronavirus disease 2019 (COVID-19); Los Angeles will be the first US city to test ...

After launching EMR-based interventions, Boston Medical Center reduced unneeded diagnostic testing and labs ordered — two markers of high quality care — a study published in the Joint Commission ...

Emerson Electric Co.EMR yesterday announced that it has successfully completed $810-million buyout of Tools and Test Equipment business of Textron Inc. TXT. The buyout, originally announced on Apr 18, ...